Evidence map›Paper›PMID 34972922›Full record

ArticleAdvances in experimental medicine and biology2021

Exhaled Breath Condensate and Dyspnea in COPD.

S Patsiris, I Papanikolaou, G Stelios, T P Exarchos, P Vlamos

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

S PatsirisGeneral Hospital of Corfu, Corfu, Greece. patsiris@hotmail.com.
I PapanikolaouGeneral Hospital of Corfu, Corfu, Greece.
G SteliosGeneral Hospital of Corfu, Corfu, Greece.
T P ExarchosBioinformatics & Human Electrophysiology Laboratory, Department of Informatics, Ionian University, Corfu, Greece. exarchos@ionio.gr.
P VlamosBioinformatics & Human Electrophysiology Laboratory, Department of Informatics, Ionian University, Corfu, Greece. vlamos@ionio.gr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) possesses a crucial position in the field of respiratory medicine as there are still unsolved issues in its whole spectrum. One promising tool that is believed to provide answers to various problems in COPD is the exhaled breath condensate (EBC). Its wealth due to its content mirrors the ongoing actions taking place in the lungs and especially the two processes blamed for the pathophysiology of COPD, the inflammation and the oxidative stress. Attempts to connect the products of the analysis of the EBC with the clinical manifestations of COPD such as dyspnea are scarce. Up to date research has shown a positive correlation between the elevated levels of some markers of EBC such as H

Indexed as

Breath TestsPulmonary Disease, Chronic ObstructiveBiomarkersDyspneaExhalationHumansHydrogen PeroxideLungBiomarkersHydrogen PeroxideChronic obstructive pulmonary diseaseDyspneaExhaled breath condensateInflammation markersOxidative stress

Identifiers

PMID34972922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.